Corcept seeks European approval of relacorilant for ovarian cancer
Corcept Therapeutics has submitted an application to the European Medicines Agency seeking approval of relacorilant for the treatment of platinum-resistant ovarian cancer. A similar…
Latest news & perspectives
Results expected soon on burixafor for myeloma stem cell transplants
Results from a clinical trial testing Exicure‘s therapy candidate burixafor (GPC-100) in stem cell transplants for people with myeloma are expected soon — and the developer…
Kernal Bio awarded up to $48M to develop blood cancer treatments
The Advanced Research Projects Agency for Health (ARPA-H) has awarded up to $48 million to Kernal Bio to support the development of more efficient,…
